Items where authors include "Smolen, JS"
Article
De Marco, G orcid.org/0000-0003-2406-161X, Zabotti, A, Baraliakos, X et al. (7 more authors) (2023) Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD Open, 9 (2). e003143. ISSN 2056-5933
Zabotti, A, De Marco, G orcid.org/0000-0003-2406-161X, Gossec, L et al. (26 more authors) (2023) EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967
van Ouwerkerk, L, Boers, M, Emery, P orcid.org/0000-0002-7429-8482 et al. (8 more authors) (2023) Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82 (4). pp. 468-475. ISSN 0003-4967
Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967
Nash, P, Kerschbaumer, A, Dörner, T et al. (26 more authors) (2021) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the Rheumatic Diseases, 80 (1). pp. 71-87. ISSN 0003-4967
Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 166. 166-. ISSN 1478-6354
Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 115. ISSN 1478-6354
Smolen, JS, Kang, YM, Yoo, WH et al. (7 more authors) (2020) Radiographic Progression Based on Baseline Characteristics From TNF Inhibitor Biosimilar Studies in Patients With Rheumatoid Arthritis. Arthritis Research and Therapy, 22. 188. ISSN 1478-6354
Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967
Smolen, JS, Choe, J-Y, Weinblatt, ME et al. (7 more authors) (2020) Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD Open, 6 (1). e001096. ISSN 2056-5933
Mease, PJ, Smolen, JS, Behrens, F et al. (11 more authors) (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the Rheumatic Diseases, 79 (1). pp. 123-131. ISSN 0003-4967
Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71 (9). pp. 1400-1412. ISSN 2326-5191
Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78 (9). pp. 1151-1159. ISSN 0003-4967
Michaud, K, Pope, JE, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2019) Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. Rheumatology and Therapy, 6 (3). pp. 409-419. ISSN 2198-6584
Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) Patients achieving sustained deep remission, deep remission or sustained remission of rheumatoid arthritis are more likely than other responders to maintain remission or low disease activity after dose reduction or withdrawal of etanercept. Arthritis Research and Therapy, 21. 164. ISSN 1478-6354
Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 21 (1). 164. ISSN 1478-6354
Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. The Lancet, 393 (10188). pp. 2303-2311. ISSN 0140-6736
Jansen, DTSL, Emery, P, Smolen, JS et al. (6 more authors) (2018) Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study. RMD Open, 4 (1). e000564. ISSN 2056-5933
Smolen, JS, Aletaha, D, Barton, A et al. (8 more authors) (2018) Rheumatoid arthritis. Nature Reviews Disease Primers, 4. 18001.
Kavanaugh, A, van Vollenhoven, RF, Fleischmann, R et al. (7 more authors) (2018) Testing Treat-to-Target Outcomes With Initial Methotrexate Monotherapy Compared With Initial Tumor Necrosis Factor Inhibitor (Adalimumab) Plus Methotrexate in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77 (2). pp. 289-292. ISSN 0003-4967
Kay, J, Schoels, MM, Dörner, T et al. (4 more authors) (2018) Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Annals of the Rheumatic Diseases, 77 (2). pp. 165-174. ISSN 0003-4967
Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967
Keystone, EC, Breedveld, FC, Heijde, DVD et al. (8 more authors) (2017) Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. RMD Open, 3 (2). e000445. ISSN 2056-5933
Coates, LC orcid.org/0000-0002-4756-663X, Gossec, L, Smolen, JS et al. (5 more authors) (2017) New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: process and challenges faced. Rheumatology, 56 (8). pp. 1251-1253. ISSN 1462-0324
Combe, B, Landewe, R, Daien, CI et al. (20 more authors) (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases, 76 (6). pp. 948-959. ISSN 0003-4967
Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967
Emery, P, Smolen, JS, Ganguli, A et al. (5 more authors) (2016) Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate. Rheumatology, 55 (8). pp. 1458-1465. ISSN 1462-0324
Tälli, S, Etcheto, A, Fautrel, B et al. (18 more authors) (2016) Patient global assessment in psoriatic arthritis – what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Joint Bone Spine, 83 (3). pp. 335-340. ISSN 1297-319X
Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967
Ramiro, S, Smolen, JS, Landewé, R et al. (7 more authors) (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases, 75 (3). pp. 490-498. ISSN 0003-4967
Stoffer, MA, Schoels, MM, Smolen, JS et al. (15 more authors) (2016) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Annals of the Rheumatic Diseases, 75 (1). pp. 16-22. ISSN 0003-4967
Smolen, JS, Breedveld, FC, Burmester, GR et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. British Journal of Sports Medicine, 75 (1). pp. 3-15. ISSN 0306-3674
Smolen, JS, Breedveld, FC, Burmester, G et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the Rheumatic Diseases, 75 (1). pp. 3-15. ISSN 0003-4967
Buch, MH orcid.org/0000-0002-8962-5642, Silva-Fernandez, L, Carmona, L et al. (18 more authors) (2015) Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology. Annals of the Rheumatic Diseases, 74 (6). pp. 963-969. ISSN 0003-4967
Smolen, JS, Emery, P, Ferraccioli, GF et al. (7 more authors) (2015) Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: The CERTAIN double-blind, randomised, placebo-controlled trial. Annals of the Rheumatic Diseases, 74 (5). pp. 843-850. ISSN 0003-4967
Baker, JF, Conaghan, PG, Smolen, JS et al. (5 more authors) (2014) Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression. Arthritis and Rheumatology, 66 (4). pp. 794-802. ISSN 2326-5191
Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967
Conference or Workshop Item
Zabotti, A, De Marco, G orcid.org/0000-0003-2406-161X, Gossec, L et al. (6 more authors) (2022) POS1079 CLINICAL CHARACTERIZATION OF PRODROMAL AND VERY EARLY PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW FOR THE DEFINITION OF CLINICAL AND IMAGING SUSPICIOUS FEATURES FOR PROGRESSION TO PSORIATIC ARTHRITIS. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Proceedings Paper
Stoffer, MA, Smolen, JS, Woolf, A et al. (23 more authors) (2014) Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project. In: Osteoarthritis and Cartilage. 2014 Osteoarthritis Research Society International (OARSI) World Congress, 24-27 Apr 2014, Paris, France. Elsevier , S437-S438.